hs-CRP: reading the inflammation marker correctly

What high-sensitivity CRP measures, the three risk bands, and why a single high result usually means retest rather than panic.

Key takeaways

  • hs-CRP measures C-reactive protein, made by the liver in response to inflammatory signaling, at the low concentrations where risk information sits.
  • Published bands: under 1 mg/L low risk, 1 to 3 average, above 3 high. Above 10 usually indicates an acute process and warrants a repeat.
  • It is non-specific. Infection, injury, hard training, poor sleep, obesity and smoking all raise it.
  • One value is not a trend. Two measurements a couple of weeks apart, taken when you are well, is the standard approach.
  • Inflammation as a causal contributor to cardiovascular risk is supported by trial evidence, most directly by CANTOS.

hs-CRP is a protein your liver produces in response to inflammatory signaling. The high-sensitivity version resolves the low range where cardiovascular risk information lives.

Published risk bands are straightforward: under 1 mg/L is low, 1 to 3 is average, above 3 is high. Above 10 usually points to something acute rather than baseline risk.

It is non-specific by design. A recent infection, an injury, a hard training block or poor sleep can all raise it, which is why timing and repeat testing matter.

What the test measures

C-reactive protein is an acute phase protein produced by the liver, largely in response to interleukin-6 signaling. When something inflammatory is happening anywhere in the body, CRP rises.

Standard CRP assays were built to detect the large elevations of active infection. The high-sensitivity version resolves the bottom of the range, between roughly 0.5 and 10 mg/L, which is where the cardiovascular risk signal lives. Same protein, finer instrument.

The three bands, and the fourth

The bands in general use come from a joint AHA and CDC scientific statement and have held up across large cohorts.

  • Under 1.0 mg/L: low relative cardiovascular risk.
  • 1.0 to 3.0 mg/L: average relative risk.
  • Above 3.0 mg/L: high relative risk.
  • Above 10 mg/L: usually an acute process such as infection or injury. Treat it as uninterpretable for risk purposes and retest once you are well.

Why a single result misleads people

hs-CRP is genuinely non-specific, and that is a feature rather than a flaw. It is a general inflammation signal, so it responds to whatever is going on.

A cold two weeks ago, a dental infection, a recent hard training block, a poor stretch of sleep, a flare of an autoimmune condition, or a recent injury will all move it. Body fat contributes independently, because adipose tissue is metabolically active and produces inflammatory signaling. Smoking raises it. Estrogen-containing medications can raise it.

This is why the sensible protocol is two measurements, ideally a couple of weeks apart, taken when you are not acutely unwell, and interpreted together.

What the trial evidence actually shows

JUPITER randomized people with normal LDL-C but elevated hs-CRP to a statin and found a reduction in cardiovascular events, which established hs-CRP as useful for identifying risk that LDL-C alone did not flag.

CANTOS went further and tested inflammation itself. Canakinumab, an antibody targeting interleukin-1 beta, lowered hs-CRP without lowering lipids and reduced recurrent cardiovascular events. That is the strongest direct evidence that inflammation contributes causally rather than merely marking risk.

What none of this means is that a raised hs-CRP tells you what is inflamed. It tells you something is, which is the beginning of a workup rather than the end of one.

How Baseline uses it

We recommend hs-CRP on the optional panel, with a repeat later if you choose lab work, and it is read next to metabolic markers rather than alone. Elevated hs-CRP with high fasting insulin and central adiposity is a recognizable metabolic pattern. Elevated hs-CRP in a lean, metabolically healthy person is a question that needs answering, not a number to optimize.

If you test and a value comes back above 10, the usual advice is to retest rather than to react. That is standard practice, not caution for its own sake.

What this means for you

Get hs-CRP measured twice, a couple of weeks apart, when you are well. Under 1 mg/L is the favorable band. A single high value usually means retest, and a persistently high one means find the source.

References

  1. Pearson et al., markers of inflammation and cardiovascular disease, AHA/CDC scientific statement, Circulation, 2003
  2. Ridker et al., JUPITER, rosuvastatin in persons with elevated C-reactive protein, New England Journal of Medicine, 2008
  3. Ridker et al., CANTOS, antiinflammatory therapy with canakinumab, New England Journal of Medicine, 2017
  4. Biomarker hub: Cardiovascular biomarkers

More in Biomarker hub